Christina Coughlin
- Immunology top 2%
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 3
- Oncology top 5%
- CAR-T cell therapy research 8
- Genetics top 10%
- Virus-based gene therapy research 5
- Chronic Lymphocytic Leukemia Research 3
- Biotechnology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- PI3K/AKT/mTOR signaling in cancer 4
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Maria WysockaKevin E. SalhanyRobert H. VonderheideGiorgio TrinchieriWilliam M. F. LeeChristopher A. HunterE ArugaAlfred E. Chang
- Cited by
- ImmunologyOncologyGenetics
- Journals
- Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (10 papers)Blood (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Christina Coughlin
33 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Immunology 922
- Oncology 839
- Genetics 119
- Biotechnology 88
- Cancer Research 152
Countries citing papers authored by Christina Coughlin
This map shows the geographic impact of Christina Coughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Coughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Coughlin more than expected).
Fields of papers citing papers by Christina Coughlin
This network shows the impact of papers produced by Christina Coughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Coughlin. The network helps show where Christina Coughlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christina Coughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 20 | |
| 2 | 2019 | 25 | |
| 3 | Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Studybreakdown → | 2018 | 302 |
| 4 | 2018 | 33 | |
| 5 | Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector IMCgp100 in advanced uveal melanoma | 2017 | 5 |
| 6 | 2015 | 4 | |
| 7 | 2014 | 49 | |
| 8 | 2010 | 26 | |
| 9 | 2009 | 34 | |
| 10 | 2009 | 3 | |
| 11 | Src pathway activation correlates with treatment resistance in breast cancer and identifies patient subsets predicted to benefit from Src inhibition | 2008 | 1 |
| 12 | 2008 | 28 | |
| 13 | 2006 | 73 | |
| 14 | 2006 | 24 | |
| 15 | 2003 | 9 | |
| 16 | 2003 | 113 | |
| 17 | 1998 | 356 | |
| 18 | 1998 | 261 | |
| 19 | 1996 | 2 | |
| 20 | B7-1 and interleukin 12 synergistically induce effective antitumor immunity. | 1995 | 106 |
About Christina Coughlin
Christina Coughlin is a scholar working on Immunology, Oncology and Ophthalmology, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (8 papers), Virus-based gene therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Advanced Breast Cancer Therapies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (922 citations), Oncology (839 citations) and Genetics (119 citations). Christina Coughlin has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Maria Wysocka, Kevin E. Salhany, Robert H. Vonderheide, Giorgio Trinchieri, William M. F. Lee, Giorgio Trinchieri, Christopher A. Hunter, E Aruga, Alfred E. Chang and Stephan A. Grupp. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.